STACY PARKER: Open Payments
NPI 1669924452 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $190 |
| ABBVIE INC. | 3 | $75 |
| Novo Nordisk Inc | 3 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Amgen Inc. | 2 | $33 |
| Stryker Corporation | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Cranial Technologies, Inc | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: BREZTRI, UBRELVY, GEMTESA, Ozempic, OTEZLA, VENACORE THROMBECTOMY CATHETER, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across FL — which companies pay providers there.
